drugset / Trial / NCT03106935

Recurrent Pregnancy Loss and Thyroid Disease

NCT03106935

RandomizedParallel-groupOpen-labelPrevention

Summary

The present study is divided into two groups ,one is the patients with subclinical hypothyroidism who has TPO antibody positive women with TSH concentrations \> 2.5 mU/L and below the upper limit of the pregnancy specific reference range ,another is TPO antibody negative with TSH concentrations greater than the pregnancy specific reference range and below 10.0 mU/L.The two groups are randomized into either the LT4 treatment group or control group by the use of a computer-generated list. The aim of our study is to determine whether the use of levothyroxine is beneficial in patients with subclinical hypothyroidism in two groups。

Timeline

Start
2015-07
Primary completion
2017-12
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levothyroxine Other / unclassified 50 ug